Here are three keynotes on the company’s financial performance in the third quarter of FY 2016.
1. U.S. sales showed a 6 percent increase, hitting $1.1 billion in the third quarter of FY 2016, while international sales reached 1.5 billion, representing a 1 percent increase from the same period the year prior.
2. The company’s sales of hospital products marked a 2 percent increase in the third quarter of FY 2016 to reach $1.6 billion, while renal sales hit $977 million, showing a 4 percent increase from the third quarter of 2015.
3. After a strong financial performance for the first three quarters of the year, Baxter is updating its financial outlook for 2016, expecting higher total sales growth and earnings.
More articles on supply chain:
GSK seeks approval of shingles vaccine: 4 things to know
Where Trump, Clinton stand on medical device tax
FDA approves Immucor’s device to detect sickle cell trait in blood
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.